中国医学影像技术
中國醫學影像技術
중국의학영상기술
CHINESE JOURNAL OF MEDICAL IMAGING TECHNOLOGY
2009年
7期
1171-1174
,共4页
蒲红%白林%赵原%黄红云%陶克言
蒲紅%白林%趙原%黃紅雲%陶剋言
포홍%백림%조원%황홍운%도극언
体层摄影术,X线计算机%双能量CT%血管造影术
體層攝影術,X線計算機%雙能量CT%血管造影術
체층섭영술,X선계산궤%쌍능량CT%혈관조영술
Tomography,X-ray computed%Dual-energy CT%Angiography
目的 比较双能量减影法与时间减影法CT脑血管成像的图像质量和扫描剂量,评价两种方法的优劣及临床应用价值.方法 对60例临床怀疑颅内血管性病变患者行CT血管成像检查,包括平扫及增强扫描,增强扫描采用双能量程序,即A球管采用80 kV,B球管采用140 kV,一次性扫描采集两个不同能量的数据.数据后处理:①用平扫+80 kV增强数据行传统去骨数字减影(时间减影法);②用80 kV及140 kV两个不同能量的数据行直接去骨减影(双能量减影法).保存减影后数据,完成容积显示(VR)和最大密度投影(MIP).将MIP及VR图像质量分为4级,比较两种处理方法的图像质量和患者所接受的平均有效放射剂量.全部病变结果均经手术或介入证实.结果 ①两种方法均清晰显示所有患者的颈内动脉颅内主干及主要分支,Willis环显示清楚;两种方法总体质量评分值差异无统计学意义(P>0.05);②两种方法均清晰显示24例动脉瘤大小、形态、与载瘤动脉关系、瘤颈及瘤轴指向;4例血管畸形病例均清晰显示异常血管团的形态和范围,动静脉畸形较好显示供血动脉及引流静脉;③时间减影法CTA患者受到的平均有效放射剂量为(26.60±0.50)mSv,双能量CTA的平均有效放射剂量为(22.40±0.50)mSv.结论 时间减影法与双能量减影法CT血管成像均能清晰显示正常颅内血管及血管性病变;双能量减影法患者受到的放射剂量更低.对扫描中不配合患者,双能量减影法去骨效果更好.
目的 比較雙能量減影法與時間減影法CT腦血管成像的圖像質量和掃描劑量,評價兩種方法的優劣及臨床應用價值.方法 對60例臨床懷疑顱內血管性病變患者行CT血管成像檢查,包括平掃及增彊掃描,增彊掃描採用雙能量程序,即A毬管採用80 kV,B毬管採用140 kV,一次性掃描採集兩箇不同能量的數據.數據後處理:①用平掃+80 kV增彊數據行傳統去骨數字減影(時間減影法);②用80 kV及140 kV兩箇不同能量的數據行直接去骨減影(雙能量減影法).保存減影後數據,完成容積顯示(VR)和最大密度投影(MIP).將MIP及VR圖像質量分為4級,比較兩種處理方法的圖像質量和患者所接受的平均有效放射劑量.全部病變結果均經手術或介入證實.結果 ①兩種方法均清晰顯示所有患者的頸內動脈顱內主榦及主要分支,Willis環顯示清楚;兩種方法總體質量評分值差異無統計學意義(P>0.05);②兩種方法均清晰顯示24例動脈瘤大小、形態、與載瘤動脈關繫、瘤頸及瘤軸指嚮;4例血管畸形病例均清晰顯示異常血管糰的形態和範圍,動靜脈畸形較好顯示供血動脈及引流靜脈;③時間減影法CTA患者受到的平均有效放射劑量為(26.60±0.50)mSv,雙能量CTA的平均有效放射劑量為(22.40±0.50)mSv.結論 時間減影法與雙能量減影法CT血管成像均能清晰顯示正常顱內血管及血管性病變;雙能量減影法患者受到的放射劑量更低.對掃描中不配閤患者,雙能量減影法去骨效果更好.
목적 비교쌍능량감영법여시간감영법CT뇌혈관성상적도상질량화소묘제량,평개량충방법적우렬급림상응용개치.방법 대60례림상부의로내혈관성병변환자행CT혈관성상검사,포괄평소급증강소묘,증강소묘채용쌍능량정서,즉A구관채용80 kV,B구관채용140 kV,일차성소묘채집량개불동능량적수거.수거후처리:①용평소+80 kV증강수거행전통거골수자감영(시간감영법);②용80 kV급140 kV량개불동능량적수거행직접거골감영(쌍능량감영법).보존감영후수거,완성용적현시(VR)화최대밀도투영(MIP).장MIP급VR도상질량분위4급,비교량충처리방법적도상질량화환자소접수적평균유효방사제량.전부병변결과균경수술혹개입증실.결과 ①량충방법균청석현시소유환자적경내동맥로내주간급주요분지,Willis배현시청초;량충방법총체질량평분치차이무통계학의의(P>0.05);②량충방법균청석현시24례동맥류대소、형태、여재류동맥관계、류경급류축지향;4례혈관기형병례균청석현시이상혈관단적형태화범위,동정맥기형교호현시공혈동맥급인류정맥;③시간감영법CTA환자수도적평균유효방사제량위(26.60±0.50)mSv,쌍능량CTA적평균유효방사제량위(22.40±0.50)mSv.결론 시간감영법여쌍능량감영법CT혈관성상균능청석현시정상로내혈관급혈관성병변;쌍능량감영법환자수도적방사제량경저.대소묘중불배합환자,쌍능량감영법거골효과경호.
Objective To compare the image quality and scanning dose of time-subtraction and dual-energy-subtraction cerebral CT angiography, and to assess clinical application value of both methods. Methods Plain and enhanced scanning were performed on 60 patients suspected cerebral vessel diseases with dual-source CT. Dual-energy mode with tube voltages of 140 and 80 kV was used in enhanced scanning, and data of two different energy were collected in one scanning. ①Traditional removed-bone digital subtraction (time-subtraction) with plain and 80 kV enhanced scanning data were obtained. Volume render (VR) and maximum intensity projection (MIP) reconstruction were finished; ②Direct removed-bone digital subtraction (dual-energy subtraction) with 80 kV and 140 kV enhanced scanning data were obtained. VR and MIP reconstruction were finished. The image quality of VR and MIP was divided into 4 grades, and were compared as well as average effective radiological dose. All the diseases were confirmed with surgery or DSA. Average effective radiological dose was compared with time-subtraction and dual-energy subtraction. Results Internal carotid artery trunk and branch and Willis circles were displayed clearly with two methods in 60 cases. No significant difference was found (P>0.05) between total quality score of the two methods. The size, shape, neck and axis point of aneurysm in 24 cases were clearly displayed, so as the shape and extent of abnormal vessel bolus in 4 cases, while arteries and veins were also clear in artery-vein malformation; ③The average radiological dose was (26.60±0.50)mSv in time-subtraction and (22.40±0.50) mSv in dual-energy subtraction. Conclusion The normal, abnormal vessels and diseases can be clearly displayed at time-subtraction and dual-energy subtraction CTA. The effect of dual-energy-subtraction is better than that of time-subtraction CTA in no-cooperation patients, and the radiological dose is lower in dual-energy CTA.